A new study from Mercer shows that employers are committed to providing their employees with benefits, despite the economic challenges they may be facing.

Insurers have succeeded in dismissing COVID-19 business-interruption lawsuits in 17 out of 23 cases heard so far, with a growing number of judges finding that some tangible alteration of a property is required to trigger coverage under commercial property policies.

A group of 16 drugmakers and the Bill and Melinda Gates Foundation signed a joint statement Sept. 30 promising that future COVID-19 therapies and vaccines will be distributed equally across the globe.

At a time of economic upheaval and uncertainty, most businesses in the US are trying to maintain their current benefits offerings to employees, a new report from Aflac finds. At the same time, employees are taking a closer look at their policies and weighing what may work best for them in the future.

President Donald Trump makes no secret he would like a COVID-19 vaccine to be available before the election. But it’s doubtful that will happen and, even after a vaccine wins FDA approval, there would be a long wait before it’s time to declare victory over the virus.

Arkansas Solicitor General Nicholas Bronni will defend before the U.S. Supreme Court the constitutionality of a state law regulating pharmacy benefit managers next Tuesday.